文献速递主动脉疾病

经皮与外科入路EVAR的成本最小化研究

Cost-minimization study of the percutaneous approach to endovascular aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2019-06-05

本研究从支付方视角,采用决策树模型比较经皮入路(P-EVAR)与外科入路(S-EVAR)行主动脉瘤腔内修复的住院期间成本;基于系统评价与荟萃分析的概率数据及2014年全国住院样本的成本参数,发现P-EVAR平均每例节省751美元,主要归因于住院时间缩短。

要点

  • P-EVAR平均每例节省751美元,主要来自住院时间缩短。
  • P-EVAR住院时间较S-EVAR减少1.4天,转换开放手术率4.3%。

核心结论

  • P-EVAR相比S-EVAR成本更低,若推广至所有主动脉瘤修复可带来显著节省。

研究设计与样本

  • 成本最小化研究,采用决策树模型从支付方视角分析指标住院期间成本;概率、相对风险和均差来自系统评价与荟萃分析,成本参数来自2014年全国住院样本。

主要发现

  • 共识别6876例腹主动脉和胸主动脉EVAR。
  • P-EVAR平均费用1287美元(95%CI 884-1835),S-EVAR为2038美元(95%CI 757-4280),平均每例节省751美元。
  • P-EVAR住院时间差异为-1.4天(95%CI -0.12至-2.68),住院日成本1190美元/天(标准误298美元)。
  • P-EVAR中转开放手术比例为4.3%。
  • 概率敏感性分析中,P-EVAR在82.6%的蒙特卡洛模拟中为成本节省策略。

关键数值与推荐

  • 基础案例中每例P-EVAR使用4个血管闭合装置,每个200美元。
  • 双向敏感性分析中,即使血管闭合装置用量增至1.5倍且单价增至1.5倍,P-EVAR仍节省成本。

临床怎么用

  • 在资源分配决策中,P-EVAR可作为更具成本效益的入路选择。
  • 关注血管闭合装置的使用数量与单价,但即使增加仍可能保持成本优势。

局限性

  • 分析为保守估计,未纳入P-EVAR后生活质量改善的获益。
  • 成本参数基于2014年全国住院样本,可能随时间变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Percutaneous access for endovascular aortic aneurysm repair (P-EVAR) is less invasive compared with surgical access for endovascular aortic aneurysm repair (S-EVAR). P-EVAR has been associated with shorter recovery and fewer wound complications. However, vascular closure devices (VCDs) are costly, and the economic effects of P-EVAR have important implications for resource allocation. The objective of our study was to estimate the differences in the costs between P-EVAR and S-EVAR. METHODS: We used a decision tree to analyze the costs from a payer perspective throughout the course of the index hospitalization. The probabilities, relative risks, and mean difference summary measures were obtained from a systematic review and meta-analysis. We modelled differences in surgical site infection, lymphocele, and the length of hospitalization. Cost parameters were derived from the 2014 National Inpatient Sample using "International Classification of Diseases, 9th Revision, Clinical Modification" codes. Attributable costs were estimated using generalized linear models adjusted by age, sex, and comorbidities. A sensitivity analysis was performed to determine the robustness of the results. RESULTS: A total of 6876 abdominal and thoracic EVARs were identified. P-EVAR resulted in a mean cost savings of $751 per procedure. The mean costs for P-EVAR were $1287 (95% confidence interval [CI], $884-$1835) and for S-EVAR were $2038 (95% CI, $757-$4280). P-EVAR procedures were converted to open procedures in 4.3% of the cases. The P-EVAR patients had a difference of -1.4 days (95% CI, -0.12 to -2.68) in the length of hospitalization at a cost of $1190/d (standard error, $298). The cost savings of P-EVAR was primarily driven by the cost differences in the length of hospitalization. In the base case, four VCDs were used per P-EVAR at $200/device. In the two-way sensitivity analysis, P-EVAR resulted in cost savings, even when 1.5 times more VCDs had been used per procedure and the cost of each VCD was 1.5 times greater. In our probabilistic sensitivity analysis, P-EVAR was the cost savings strategy for 82.6% of 10,000 Monte Carlo simulations when simultaneously varying parameters across their uncertainty ranges. CONCLUSIONS: P-EVAR had lower costs compared with S-EVAR and could result in dramatic cost savings if extrapolated to the number of aortic aneurysms repaired. Our analysis was a conservative estimate that did not account for the improved quality of life after P-EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hong JC, Yang GK, Delarmente BA, et al. Cost-minimization study of the percutaneous approach to endovascular aortic aneurysm repair. J Vasc Surg. 2019. PMID: 31176637. doi:10.1016/j.jvs.2019.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。